Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study.
artificial intelligence
attention heatmaps
attention-based multiple-instance learning
biomarker
colorectal cancer
computational pathology
multi-input models
oncogenic mutation
self-supervised learning
Journal
Cell reports. Medicine
ISSN: 2666-3791
Titre abrégé: Cell Rep Med
Pays: United States
ID NLM: 101766894
Informations de publication
Date de publication:
18 04 2023
18 04 2023
Historique:
received:
25
09
2022
revised:
28
12
2022
accepted:
24
02
2023
medline:
21
4
2023
pubmed:
24
3
2023
entrez:
23
3
2023
Statut:
ppublish
Résumé
Deep learning (DL) can predict microsatellite instability (MSI) from routine histopathology slides of colorectal cancer (CRC). However, it is unclear whether DL can also predict other biomarkers with high performance and whether DL predictions generalize to external patient populations. Here, we acquire CRC tissue samples from two large multi-centric studies. We systematically compare six different state-of-the-art DL architectures to predict biomarkers from pathology slides, including MSI and mutations in BRAF, KRAS, NRAS, and PIK3CA. Using a large external validation cohort to provide a realistic evaluation setting, we show that models using self-supervised, attention-based multiple-instance learning consistently outperform previous approaches while offering explainable visualizations of the indicative regions and morphologies. While the prediction of MSI and BRAF mutations reaches a clinical-grade performance, mutation prediction of PIK3CA, KRAS, and NRAS was clinically insufficient.
Identifiants
pubmed: 36958327
pii: S2666-3791(23)00086-1
doi: 10.1016/j.xcrm.2023.100980
pmc: PMC10140458
pii:
doi:
Substances chimiques
Proto-Oncogene Proteins B-raf
EC 2.7.11.1
Proto-Oncogene Proteins p21(ras)
EC 3.6.5.2
Biomarkers
0
Class I Phosphatidylinositol 3-Kinases
EC 2.7.1.137
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
100980Informations de copyright
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests For transparency, we provide the following information: J.N.K. declares consulting services for Owkin, France; Panakeia, UK; and DoMore Diagnostics, Norway. P.Q. and N.P.W. declare research funding from Roche and PQ consulting and speaker services for Roche. P.Q. is a National Institute of Health Research senior investigator.
Références
Nat Cancer. 2020 Aug;1(8):789-799
pubmed: 33763651
Nat Med. 2019 Jul;25(7):1054-1056
pubmed: 31160815
Int J Cancer. 2021 Aug 1;149(3):728-740
pubmed: 33851412
Nat Rev Clin Oncol. 2019 Nov;16(11):703-715
pubmed: 31399699
Am J Surg Pathol. 2009 Jan;33(1):126-33
pubmed: 18830122
J Hepatol. 2022 Jul;77(1):116-127
pubmed: 35143898
Nat Cancer. 2022 Sep;3(9):1026-1038
pubmed: 36138135
Lancet Oncol. 2021 Jan;22(1):132-141
pubmed: 33387492
Nat Med. 2018 Oct;24(10):1559-1567
pubmed: 30224757
Cancer Res. 1998 Nov 15;58(22):5248-57
pubmed: 9823339
J Thorac Oncol. 2010 Sep;5(9):1315-6
pubmed: 20736804
ESMO Open. 2022 Apr;7(2):100400
pubmed: 35247870
Gastric Cancer. 2019 Nov;22(6):1193-1203
pubmed: 31111275
JAMA Oncol. 2022 Oct 1;8(10):1456-1465
pubmed: 36006624
Med Image Anal. 2022 Jul;79:102474
pubmed: 35588568
Cancer Cell. 2022 Aug 8;40(8):865-878.e6
pubmed: 35944502
Cancer Cell. 2023 Jan 9;41(1):5-6
pubmed: 36368319
Theranostics. 2020 Sep 2;10(24):11080-11091
pubmed: 33042271
ESMO Open. 2022 Apr;7(2):100429
pubmed: 35397433
Am J Pathol. 2002 Sep;161(3):1087-97
pubmed: 12213737
Histopathology. 2022 Jun;80(7):1121-1127
pubmed: 35373378
Nature. 2017 Feb 2;542(7639):115-118
pubmed: 28117445
J Pathol. 2022 Jul;257(4):430-444
pubmed: 35342954
Nat Med. 2019 Aug;25(8):1301-1309
pubmed: 31308507
J Natl Cancer Inst. 2015 Mar 13;107(6):djv045
pubmed: 25770147
Gastroenterology. 2020 Oct;159(4):1406-1416.e11
pubmed: 32562722
Cancer Res. 2005 Sep 15;65(18):8072-8
pubmed: 16166278
J Pathol. 2022 Jan;256(1):50-60
pubmed: 34561876
Br J Cancer. 2021 Feb;124(4):686-696
pubmed: 33204028
Am J Surg Pathol. 2012 May;36(5):744-52
pubmed: 22314188
Nature. 2021 Jun;594(7861):106-110
pubmed: 33953404
Nat Med. 2022 Mar;28(3):575-582
pubmed: 35314822
NPJ Precis Oncol. 2023 Mar 28;7(1):35
pubmed: 36977919
Lancet. 2007 Dec 15;370(9604):2020-9
pubmed: 18083404
Immunity. 2016 Mar 15;44(3):698-711
pubmed: 26982367
J Pathol. 2022 Mar;256(3):269-281
pubmed: 34738636
Nat Rev Cancer. 2021 Mar;21(3):199-211
pubmed: 33514930
Br J Cancer. 2016 Nov 22;115(11):1359-1366
pubmed: 27811854
Nat Rev Gastroenterol Hepatol. 2020 Oct;17(10):591-592
pubmed: 32620817
World J Gastroenterol. 2020 Oct 28;26(40):6207-6223
pubmed: 33177794
Med Image Anal. 2022 Jul;79:102464
pubmed: 35596966
BMJ. 2011 Nov 09;343:d6751
pubmed: 22074710
Nat Commun. 2021 Jul 20;12(1):4423
pubmed: 34285218
Lancet Digit Health. 2021 Dec;3(12):e763-e772
pubmed: 34686474
Gut. 2006 Aug;55(8):1145-50
pubmed: 16469791
J Clin Oncol. 2011 Oct 1;29(28):3761-7
pubmed: 21876077
Histopathology. 2007 Jan;50(1):103-12
pubmed: 17204025
Nat Cancer. 2020 Aug;1(8):800-810
pubmed: 35122049
Med Image Anal. 2023 Jan;83:102645
pubmed: 36270093
J Clin Oncol. 2011 Apr 1;29(10):1261-70
pubmed: 21383284
Scand J Gastroenterol. 2004 Aug;39(8):748-53
pubmed: 15513360